Mike Nerenberg

Mike Nerenberg is an accomplished medical professional with extensive experience in leadership roles within the biotechnology and medical diagnostics sectors. Currently serving as Chief Medical Officer at Exagen Inc. since May 2023, Nerenberg previously held positions including SVP of Medical and Clinical Affairs at Curative and Chief Medical Officer at Alamar Biosciences, Inc., where contributions included the development of assays to assess liver fibrosis and stem cell engraftment. Nerenberg's background also includes significant roles at Molecular Stethoscope, DifferentialDx, LLC, Genoptix, and Molecular Reflections Inc., showcasing expertise in molecular diagnostics, commercialization, and medical affairs. Nerenberg holds a Doctor of Medicine from Yale School of Medicine and has completed postdoctoral training in Molecular Medicine at the National Institutes of Health, alongside a Bachelor's degree in Chemistry-Biophysics from the University of Chicago.